Projects per year
Personal profile
Specialisation
Medical Oncology
Research interests
Hanneke Wilmink is Professor Medical Oncology at the Amsterdam UMC. She specialises in:
- Upper gastro-intestinal oncology, with a special focus on pancreatic cancer
- Improving the prognosis of pancreatic cancer patients through innovative clinical and translational research
- The clinical trial participants as well as the existing biobank are the main source for the development and validation of prognostic and predictive markers in blood and tumor tissues.
- Dutch Pancreatic Cancer Group: improving outcomes of pancreatic cancer (dpcg.nl)
- Cancer and metabolism
- To develop new therapies with a specific focus on cancer metabolism.
Activities
- Staff member Department of Medical Oncology, Amsterdam UMC
- Board member of the Dutch Pancreatic Cancer Group (DPCG)
Fingerprint
Dive into the research topics where Johanna Wilmink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
CTO - GO44479 / IMCODE003IMCODE003: A PHASE II, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF ADJUVANT AUTOGENE CEVUMERAN PLUS ATEZOLIZUMAB AND mFOLFIRINOX VERSUS mFOLFIRINOX ALONE IN PATIENTS WITH RESECTED ...
Wilmink, J. (Principal investigator)
06/05/2025 → 01/03/2030
Project: Research
-
Swim Muiden tbv PREMAB: Swim Muiden voor alvleesklierkanker tbv de PREMAB studie - toekenning vanuit Stichting Fight Cancer via de AMC Foundation
Wilmink, J. (Principal investigator)
01/03/2025 → 31/12/2026
Project: Research
-
NEODISCO: Neoadjuvant gemcitabine and cisplatin in combination with perioperative pembrolizumab versus upfront surgery for patients with primary resectable and borderline resectable perihilar and distal chol...
Wilmink, J. (Principal investigator)
11/02/2025 → 10/02/2028
Project: Research
-
CTO AMGEN193 - 20230223: a multicenter, open-label, phase 1b/2 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of AMG 193 alone or in combination with other therapies in subjects with advanced gas...
Wilmink, J. (Principal investigator)
29/10/2024 → 30/10/2027
Project: Research
-
PREOPANC-5 - KWF 15235: 15235 / PREOPANC-5 study
Wilmink, J. (Principal investigator)
01/06/2024 → 30/11/2027
Project: Research
-
RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Molenaar, R. J., Radivoyevitch, T. & Wilmink, J. W., 2017, In: Journal of the National Cancer Institute. 109, 8, p. djx103Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study
Kordes, S., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J. J. G. H. M., van der Vliet, H. J., Kapiteijn, E., van Laarhoven, H. W. M., Richel, D. J., Klinkenbijl, J. H. G., Meijer, S. L. & Wilmink, J. W., 2014, In: International journal of radiation oncology, biology, physics. 90, 1, p. 190-196Research output: Contribution to journal › Article › Academic › peer-review
-
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J. & Wilmink, J. W., 2015, In: lancet oncology. 16, 7, p. 839-847Research output: Contribution to journal › Article › Academic › peer-review
-
Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
Deenen, M. J., Klümpen, H.-J., Richel, D. J., Sparidans, R. W., Weterman, M. J., Beijnen, J. H., Schellens, J. H. M. & Wilmink, J. W., 2012, In: Investigational new drugs. 30, 4, p. 1557-1565Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
Rombouts, S. J., Mungroop, T. H., Heilmann, M. N., van Laarhoven, H. W., Busch, O. R., Molenaar, I. Q., Besselink, M. G. & Wilmink, J. W., 2016, In: Journal of Cancer. 7, 13, p. 1861-1866Research output: Contribution to journal › Article › Academic › peer-review
Datasets
-
Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis
Besselink, M. G. (Creator), van Erning, F. N. (Contributor), Mackay, T. M. (Creator), van der Geest, L. G. M. (Contributor), Groot, K. B. (Contributor), van Laarhoven, H. W. M. (Contributor), Bonsing, B. A. (Creator), Wilmink, J. W. (Creator), van Santvoort, H. C. (Contributor), de Vos-Geelen, J. (Contributor), van Eijck, C. H. J. (Contributor), Busch, O. R. (Creator) & Lemmens, V. E. (Creator), Taylor & Francis, 2018
DOI: 10.6084/m9.figshare.7146152.v1, https://tandf.figshare.com/articles/Association_of_the_location_of_pancreatic_ductal_adenocarcinoma_head_body_tail_with_tumor_stage_treatment_and_survival_a_population-based_analysis/7146152/1
Dataset
-
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
Strijker, M. (Creator), van Veldhuisen, E. (Contributor), van der Geest, L. G. (Contributor), Busch, O. R. (Creator), Bijlsma, M. F. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. (Creator), van Hooft, J. E. (Contributor), Verheij, J. (Creator), de Vos-Geelen, J. (Contributor), Wilmink, J. W. (Creator), Steyerberg, W. E. W. (Creator), Besselink, M. G. (Creator) & van Laarhoven, H. W. (Contributor), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.14169623.v1, https://tandf.figshare.com/articles/dataset/Readily_available_biomarkers_predict_poor_survival_in_metastatic_pancreatic_cancer/14169623/1
Dataset
-
Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis
Latenstein, A. E. J. (Creator), Mackay, T. M. (Creator), Creemers, G.-J. (Contributor), van Eijck, C. H. J. (Contributor), de Groot, J. W. B. (Contributor), Haj Mohammad, N. (Contributor), Homs, M. Y. V. (Creator), van Laarhoven, H. W. M. (Contributor), Molenaar, I. Q. (Contributor), ten Tije, B.-J. (Contributor), de Vos-Geelen, J. (Contributor), Besselink, M. G. (Creator), van der Geest, L. G. M. (Contributor) & Wilmink, J. W. (Creator), Taylor & Francis, 2020
DOI: 10.6084/m9.figshare.11854743.v1, https://tandf.figshare.com/articles/dataset/Implementation_of_contemporary_chemotherapy_for_patients_with_metastatic_pancreatic_ductal_adenocarcinoma_a_population-based_analysis/11854743/1
Dataset
-
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
Strijker, M. (Creator), van Veldhuisen, E. (Contributor), van der Geest, L. G. (Contributor), Busch, O. R. (Creator), Bijlsma, M. F. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. (Creator), van Hooft, J. E. (Contributor), Verheij, J. (Creator), de Vos-Geelen, J. (Contributor), Wilmink, J. W. (Creator), Steyerberg, W. E. W. (Contributor), Besselink, M. G. (Creator) & van Laarhoven, H. W. (Contributor), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.14169623.v2, https://tandf.figshare.com/articles/dataset/Readily_available_biomarkers_predict_poor_survival_in_metastatic_pancreatic_cancer/14169623/2
Dataset
-
Readily available biomarkers predict poor survival in metastatic pancreatic cancer
Strijker, M. (Creator), van Veldhuisen, E. (Contributor), van der Geest, L. G. (Contributor), Busch, O. R. (Creator), Bijlsma, M. F. (Creator), Haj Mohammad, N. (Contributor), Homs, M. Y. (Creator), van Hooft, J. E. (Contributor), Verheij, J. (Creator), de Vos-Geelen, J. (Contributor), Wilmink, J. W. (Creator), Steyerberg, W. E. W. (Contributor), Besselink, M. G. (Creator) & van Laarhoven, H. W. (Contributor), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.14169623, https://tandf.figshare.com/articles/dataset/Readily_available_biomarkers_predict_poor_survival_in_metastatic_pancreatic_cancer/14169623
Dataset